A half-century-old “bet hedging” hypothesis explains the effectiveness of many drug combinations.

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

Who will be chosen for The Medicine Maker 2018 Power List? The power is in your hands.

London’s Science Museum highlights superbugs and the stars that fight against them in a new exhibition.

Some patients, particularly children, find medicines unpalatable – and genetics could be the cause.

The year 2018 will be one of yet more drug approvals, but which areas will be neglected?

Exploring the Future of Bioprocessing Together.

Interviewing Rickey Lu, Director of Manufacturing Technology Innovation, at AstraZeneca.

A consortium funded by Horizon 2020 aims to bring biopharma manufacturing into the 21st century.

MilliporeSigma has developed a CHO cell perfusion medium specifically designed for untensified perfusion processes.